56. ベーチェット病 Behcet disease Clinical trials / Disease details
臨床試験数 : 76 / 薬物数 : 110 - (DrugBank : 32) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000031637 | 2020-04-10 | 1990-01-01 | Behcet’s Uveitis Therapy (BUT) Study | Behcet’s Uveitis Therapy (BUT) Study | Uveitis in Behcet’s Disease | Arm A: Interferon Alpha-2a;Arm B:Adalimumab;Arm C:Cyclosporine; | The First Affiliated Hospital of Chongqing Medical University | NULL | Pending | Both | Arm A:90;Arm B:90;Arm C:90; | Phase 4 | China | ||
| 2 | NCT03209219 (ClinicalTrials.gov) | June 30, 2017 | 4/7/2017 | Interferon a2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis | Randomized Prospective Comparative Study of Interferon a2a and Cyclosporine in Patients With Refractory Behçet's Disease Uveitis | Behçet Disease;Uveitis | Drug: Interferon Alfa-2A;Drug: Cyclosporine Pill | Peking Union Medical College Hospital | NULL | Completed | 18 Years | 65 Years | All | 28 | Phase 3 | China |